These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17382495

  • 1. 5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter.
    Sogawa C, Sogawa N, Tagawa J, Fujino A, Ohyama K, Asanuma M, Funada M, Kitayama S.
    Toxicol Lett; 2007 Apr 05; 170(1):75-82. PubMed ID: 17382495
    [Abstract] [Full Text] [Related]

  • 2. Dual actions of 5-MeO-DIPT at the serotonin transporter and serotonin 5-HT1A receptor in the mouse striatum and prefrontal cortex.
    Hagino Y, Hall FS, Uhl GR, Sora I, Ikeda K.
    Neuropsychopharmacol Rep; 2021 Mar 05; 41(1):91-101. PubMed ID: 33547882
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
    Williams MT, Herring NR, Schaefer TL, Skelton MR, Campbell NG, Lipton JW, McCrea AE, Vorhees CV.
    Neuropsychopharmacology; 2007 Jun 05; 32(6):1404-20. PubMed ID: 17047665
    [Abstract] [Full Text] [Related]

  • 5. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.
    Nagai F, Nonaka R, Satoh Hisashi Kamimura K.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):132-7. PubMed ID: 17223101
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone.
    McLaughlin G, Morris N, Kavanagh PV, Power JD, Dowling G, Twamley B, O'Brien J, Talbot B, Walther D, Partilla JS, Baumann MH, Brandt SD.
    Drug Test Anal; 2017 Mar 22; 9(3):358-368. PubMed ID: 27524685
    [Abstract] [Full Text] [Related]

  • 9. The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor.
    Jin ZL, Gao N, Zhou D, Chi MG, Yang XM, Xu JP.
    Pharmacol Biochem Behav; 2012 Jan 22; 100(3):431-9. PubMed ID: 22005599
    [Abstract] [Full Text] [Related]

  • 10. A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
    Tanaka E, Kamata T, Katagi M, Tsuchihashi H, Honda K.
    Forensic Sci Int; 2006 Nov 10; 163(1-2):152-4. PubMed ID: 16406422
    [Abstract] [Full Text] [Related]

  • 11. Abuse liability profile of three substituted tryptamines.
    Gatch MB, Forster MJ, Janowsky A, Eshleman AJ.
    J Pharmacol Exp Ther; 2011 Jul 10; 338(1):280-9. PubMed ID: 21474568
    [Abstract] [Full Text] [Related]

  • 12. Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (foxy).
    Nakagawa T, Kaneko S.
    J Pharmacol Sci; 2008 Jan 10; 106(1):2-8. PubMed ID: 18198474
    [Abstract] [Full Text] [Related]

  • 13. A foxy intoxication.
    Wilson JM, McGeorge F, Smolinske S, Meatherall R.
    Forensic Sci Int; 2005 Feb 10; 148(1):31-6. PubMed ID: 15607587
    [Abstract] [Full Text] [Related]

  • 14. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors.
    Halberstadt AL, Brandt SD, Walther D, Baumann MH.
    Psychopharmacology (Berl); 2019 Mar 10; 236(3):989-999. PubMed ID: 30904940
    [Abstract] [Full Text] [Related]

  • 15. Selective inhibition of monoamine neurotransmitter transporters by synthetic local anesthetics.
    Sato T, Kitayama S, Mitsuhata C, Ikeda T, Morita K, Dohi T.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb 10; 361(2):214-20. PubMed ID: 10685879
    [Abstract] [Full Text] [Related]

  • 16. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
    Nightingale B, Dersch CM, Boos TL, Greiner E, Calhoun WJ, Jacobson AE, Rice KC, Rothman RB.
    J Pharmacol Exp Ther; 2005 Aug 10; 314(2):906-15. PubMed ID: 15860577
    [Abstract] [Full Text] [Related]

  • 17. N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
    Shulgin AT, Carter MF.
    Commun Psychopharmacol; 1980 Aug 10; 4(5):363-9. PubMed ID: 6949674
    [No Abstract] [Full Text] [Related]

  • 18. The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats.
    Noworyta-Sokołowska K, Górska AM, Gołembiowska K.
    Pharmacol Rep; 2018 Oct 10; 70(5):890-895. PubMed ID: 30096487
    [Abstract] [Full Text] [Related]

  • 19. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
    Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB.
    Psychopharmacology (Berl); 2014 Oct 10; 231(21):4135-44. PubMed ID: 24800892
    [Abstract] [Full Text] [Related]

  • 20. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
    Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE.
    J Neural Transm (Vienna); 2009 Dec 10; 116(12):1591-9. PubMed ID: 19756361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.